1)  Sterol regulatory element binding protein-1c
					 
	
					
				
				 
	
					
				固醇调节元件结合蛋白-1c
				1.
					Sterol regulatory element binding protein-1c and hepatic steatosis;
					 
					
						
						 
					
						固醇调节元件结合蛋白-1c与肝脂肪变性
					2.
					Objective:To evaluate the effect of Tiopronin on hepatic expression of sterol regulatory element binding protein-1c(SREBP-1c) in rats with alcoholic liver disease(ALD).
						
						目的:观察硫普罗宁对酒精性肝病(ALD)大鼠肝组织固醇调节元件结合蛋白-1c(SREBP-1c)表达的影响。
					
					2)  SREBP-1c
					 
	
					
				
				 
	
					
				固醇调节元件结合蛋白-1c
				1.
					Advanced Research of SREBP-1c Transcriptional Regulation in Fatty Liver Formation;
					 
					
						
						 
					
						固醇调节元件结合蛋白-1c在肝脂肪合成中转录调节
					2.
					Objective:To study the effect of TNF-α(Tumor Necrosis Factor-α) on the expression of Sterol Regulatory Element Binding Protein(SREBP) Cleavage-Activating Protein (SCAP) and SREBP-1c in a model of hepatocyte steatosis,so as to explore the role and possible mechanism by which TNF-αacts on the SCAP-SREBP-1c pathway of lipid synthesis in nonalcoholic fatty liver disease(NAFLD).
						
						目的:通过本研究探讨TNF-α对肝细胞脂肪变性模型固醇调节元件结合蛋白裂解激活蛋白(SCAP)及固醇调节元件结合蛋白-1c(SREBP-1c)表达的影响,探讨TNF-α在非酒精性脂肪性肝病(NAFLD)SCAP-SREBP-1c脂质合成通路中的作用及可能机制。
					3.
					OBJECTIVE To study the therapeutic effect of Jueming prescription(JMP)on nonalcoholic fatty liver disease in obese rat model,and investigate its influence on the expression of sterol regulatory element binding-protein 1c(SREBP-1c)in the liver.
						
						目的:观察决明方对肥胖大鼠非酒精性脂肪肝的干预作用及对肝脏固醇调节元件结合蛋白-1c(SREBP-1c)表达的影响。
					
					3)  sterol regulatory element binding proteins-1c
					 
	
					
				
				 
	
					
				固醇调节元件结合蛋白-1c
				1.
					Objective To investigate the expression of sterol regulatory element binding proteins-1c(SREBP-1c)in the liver tissues during fatty diet-induced non-alcoholic steatohepatitis(NASH) in rats and to explore the relationship between the expression of SREBP-1c and nonalcoholic steatohepatitis.
						
						目的观察高脂饮食诱导大鼠非酒精性脂肪性肝炎(NASH)过程中肝组织固醇调节元件结合蛋白-1c(SREBP-1c)的表达变化,探讨SREBP-1c与NASH的关系。
					2.
					Objective To explore the relationship between the 54G/C single nucleotide polymorphism of exon 18c of sterol regulatory element binding proteins-1c and type 2 diabetes mellitus in Chinese Han population from Hubei province.
						
						目的探讨中国湖北地区汉族人群固醇调节元件结合蛋白-1c(SREBP-1c)基因外显子18c 54G/ C单核苷酸多态性(single nucleotide polymorphism,SNP)与2型糖尿病之间的关系。
					
					4)  sterol regulatory element-binding protein-1c
					 
	
					
				
				 
	
					
				固醇调节元件结合蛋白-1c
				1.
					Association between genetic polymorphism of sterol regulatory element-binding protein-1c and Uygur patients with coronary heart disease in Xinjiang
						
						固醇调节元件结合蛋白-1c基因54G/C多态性与新疆维吾尔族冠心病的相关性
					
					5)  Sterol regulatory element binding protein-1c of the liver
					 
	
					
				
				 
	
					
				肝固醇调节元件结合蛋白-1c
			
					6)  SREBPs
					 
	
					
				
				 
	
					
				固醇调节元件结合蛋白
				1.
					Advance in SREBPs in Animal Lipid Metabolism;
					 
					
						
						 
					
						固醇调节元件结合蛋白在动物脂肪代谢中的研究进展
					2.
					The Study of the SREBPs;
					 
					
						
						 
					
						固醇调节元件结合蛋白(SREBPs)的研究进展
					补充资料:麦固醇 ,谷固醇
		药物名称:谷固醇
英文名:Sitosterol
别名: β-谷固醇;谷甾醇;麦固醇 ,谷固醇
外文名:Sitosterol
适应症: 用于Ⅱ型高脂血症及预防动脉粥样硬化。
用量用法: 口服:每次服混悬剂20~30ml,每日3次,饭前或饭后即服。
注意事项: 大剂量时可出现食欲减退、胃肠道痉挛、腹泻等。
规格: 混悬剂:20%。
类别:调节血脂及抗动脉硬化药
		英文名:Sitosterol
别名: β-谷固醇;谷甾醇;麦固醇 ,谷固醇
外文名:Sitosterol
适应症: 用于Ⅱ型高脂血症及预防动脉粥样硬化。
用量用法: 口服:每次服混悬剂20~30ml,每日3次,饭前或饭后即服。
注意事项: 大剂量时可出现食欲减退、胃肠道痉挛、腹泻等。
规格: 混悬剂:20%。
类别:调节血脂及抗动脉硬化药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
	参考词条